Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
83.84    -0.74 (-0.87%)
Bid:
83.94
Ask:
84.16
Spread: 0.22 (0.262%)
Market Cap: £2.91b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Zero carbon ready homes trial visit

27 Jun 2023 07:00

RNS Number : 9680D
Taylor Wimpey PLC
27 June 2023
Β 

Β 

Β 

Β 

27 June 2023

Taylor Wimpey plc

Investor and analyst visit to Taylor Wimpey's zero carbon ready homes trial

Β 

Taylor Wimpey will be hosting a visit for institutional investors and analysts to view our recently launched flagship zero carbon ready homes trial at our Chilton Woods development in Sudbury, Suffolk.

This is the industry's first research concept testing low carbon technologies through multi-specification prototype homes on a live development site. The prototype homes will help identify new ways to increase the energy efficiency of our homes as well as identify the challenges that will need to be overcome to do so at scale.

Β 

The innovative trial seeks to demonstrate how the industry can deliver homes compliant with the incoming Future Home Standard (FHS) through varying combinations of technologies and enhanced building fabric. As part of the trial, Taylor Wimpey is challenging itself as well as its supply chain partners, and working closely with engineers and energy experts to introduce the most cutting-edge products into the homes to meet the requirements of FHS. The homes have been expertly designed to ensure that the new technologies work seamlessly for customers' living requirements.

Β 

The launch is a major milestone following the recent publication of Taylor Wimpey's Net Zero Transition Plan, which will ensure Taylor Wimpey reaches net zero five years ahead of the government's target.

Β 

The visit will include a presentation in our information centre by Taylor Wimpey senior management, followed by a tour of the prototype homes.

No material financial or other material information will be shared during the visit.

Β 

-Ends-

Β 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

James Gray

Β 

Β 

Notes to editors:

Taylor Wimpey plc is a customer-focused homebuilder operating at a local level from 22 regional businesses across the UK. We also have operations in Spain. Our purpose is to build great homes and create thriving communities.

For further information please visit the Group's website: www.taylorwimpey.co.uk/corporate

Follow us on Twitter @TaylorWimpeyplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCNKABPCBKDCAB
Date   Source Headline
12th Jun 20267:00 amRNSDirector/PDMR Shareholding
9th Jun 20263:11 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSDirectorate change
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 202610:41 amRNSHolding(s) in Company
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20269:49 amRNSDirector/PDMR Shareholding
15th May 20261:32 pmRNSHolding(s) in Company
14th May 20267:00 amRNSTransaction in Own Shares
11th May 20264:10 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20263:30 pmRNSHolding(s) in Company
6th May 202611:05 amRNSHolding(s) in Company
5th May 202611:28 amRNSHolding(s) in Company
1st May 202611:53 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:34 pmRNSDirector/PDMR Shareholding
28th Apr 20264:23 pmRNSResult of AGM
28th Apr 20267:00 amRNSTrading Statement
23rd Apr 20269:25 amRNSTransaction in Own Shares
20th Apr 20268:41 amRNSDirector Declaration
16th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20263:42 pmRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:36 pmRNSTotal Voting Rights
30th Mar 20262:19 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:22 pmRNSHolding(s) in Company
20th Mar 20263:37 pmRNSAnnual Financial Report and Notice of Meeting
19th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
6th Mar 202611:44 amRNSDirector/PDMR Shareholding
5th Mar 20267:01 amRNSShare Buyback Programme
5th Mar 20267:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
2nd Mar 202611:50 amRNSTotal Voting Rights
10th Feb 20263:19 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:17 pmRNSTotal Voting Rights
22nd Jan 20263:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Statement
9th Jan 20262:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202612:02 pmRNSTotal Voting Rights
2nd Jan 202611:59 amRNSBlock listing Interim Review
2nd Jan 202611:54 amRNSBlock listing Interim Review
15th Dec 20254:17 pmRNSDirector/PDMR Shareholding
9th Dec 20254:21 pmRNSDirector/PDMR Shareholding
9th Dec 20254:18 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.